Dr Fatima Valdes Mora (Fa) joined Children’s Cancer Institute in 2020 to establish a new research group as a Team Leader. Fa has previously worked at the Garvan Institute, where she established the Histone Variants Group. She is also a Conjoint Senior Lecturer at UNSW Sydney.
Fa’s team collaborates with ZERO to characterise the epigenetic-driven tumours of patients currently enrolled in ZERO to further understand their molecular role on tumour profession. Their goal is to propose novel and personalised epigenetic-based therapy for children with cancer.
Find out more about Fa on the Children's Cancer Institute website
